Neil Gupta
Overview
Explore the profile of Neil Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
231
Citations
3852
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu K, Elmunzer B, Wani S, Taft T, Walsh C, Arain M, et al.
Endosc Int Open
. 2024 Feb;
12(2):E324-E331.
PMID: 38420150
The Bethesda ERCP Skill Assessment Tool (BESAT) is a video-based assessment tool of technical endoscopic retrograde cholangiopancreatography (ERCP) skill with previously established validity evidence. We aimed to assess the discriminative...
12.
Adler A, Wroe E, Atzori A, Bay N, Bekele W, Bhambhani V, et al.
BMJ Open
. 2024 Jan;
14(1):e074182.
PMID: 38296295
Introduction: The Package of Essential Noncommunicable Disease Interventions-Plus (PEN-Plus) is a strategy decentralising care for severe non-communicable diseases (NCDs) including type 1 diabetes, rheumatic heart disease and sickle cell disease,...
13.
Subba K, Gupta N, Woodman J, Dhingra V
JNMA J Nepal Med Assoc
. 2024 Jan;
61(266):814-818.
PMID: 38289767
Keywords: case report; drain fragment retrieval; fractured pelvic drain; pelvic drain remnant.
14.
Saseetharran A, Hiebert L, Gupta N, Nyirahabihirwe F, Kamali I, Ward J
BMC Infect Dis
. 2023 Dec;
23(1):866.
PMID: 38071291
Background And Aims: Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment. This scoping review...
15.
Hofmeister M, Gupta N
MMWR Morb Mortal Wkly Rep
. 2023 Oct;
72(42):1128-1133.
PMID: 37856325
Hepatitis A is acquired through the fecal-oral route and is preventable by a safe and effective vaccine. Although hepatitis A is generally mild and self-limited, serious complications, including death, can...
16.
Njuguna H, Hiebert L, Harris A, Morgan R, Gupta N, Ward J
J Infect Dis
. 2023 Sep;
228(Suppl 3):S148-S153.
PMID: 37703342
In 2016, the World Health Organization (WHO) released the Global Health Sector Strategy (GHSS) setting goals for global hepatitis elimination. To inform new or revised viral hepatitis national strategic action...
17.
Montgomery M, Randall L, Morrison M, Gupta N, Doshani M, Teshale E
Public Health Rep
. 2023 Sep;
:333549231193508.
PMID: 37667621
The United States has a goal to eliminate hepatitis C as a public health threat by 2030. To accomplish this goal, hepatitis C virus (HCV) care cascades (hereinafter, HCV cascades)...
18.
Moorman A, Bixler D, Teshale E, Hofmeister M, Roberts H, Chapin-Bardales J, et al.
Public Health Rep
. 2023 Jul;
:333549231181348.
PMID: 37480274
The overlapping epidemics of hepatitis C virus (HCV) and HIV infection stem from underlying behaviors and health disparities among disproportionately affected populations, especially people who inject drugs (PWID). Characterizing the...
19.
Hofmeister M, Yin S, Nelson N, Weng M, Gupta N
Public Health Rep
. 2023 Jul;
333549231184007.
PMID: 37480244
Objectives: The incidence of hepatitis A declined in the United States following the introduction of hepatitis A vaccines, before increasing in the setting of recent widespread outbreaks associated with person-to-person...
20.
Lewis K, Barker L, Jiles R, Gupta N
Clin Infect Dis
. 2023 Jul;
77(10):1413-1415.
PMID: 37417196
During January 2017-March 2020, approximately 2.2 million noninstitutionalized civilian US adults had hepatitis C; one-third were unaware of their infection. Prevalence was substantially higher among persons who were uninsured or...